Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment

Table 1 Patient characteristics n (%)

Variables	Patient
Gender
Male	54 (60)
Female	36 (40)
Age
≤ 60 yr	50 (55.6)
> 60 yr	40 (44.4)
Primary surgery
Anterior resection	54 (60)
Abdominoperineal resection	32 (35.6)
Hartmann	2 (2.2)
Local excision	2 (2.2)
Neoadjuvant chemoradiotherapy for primary tumor
Yes	18 (20)
No	72 (80)
Primary tumor stage
I	6 (6.6)
IIA	8 (8.8)
IIB	11 (12.2)
IIIA	10 (11.1)
IIIB	20 (22.2)
IIIC	26 (28.8)
Unknown	9 (10)
Serum CEA1
≤ 5 ng/mL	27 (30)
> 5 ng/mL	48 (53.3)
Unknown	15 (16.7)
Preoperative chemoradiotherapy for recurrent tumor2
Yes	10 (24.4)
No	31 (75.6)
Surgery for recurrent tumor	41 (45.6)
Anterior resection	2 (4.9)
Abdominoperineal resection	30 (73.2)
Combined organ excision3	5 (12.2)
Total pelvic exenteration	4 (9.8)
Conservative therapy	49 (54.4)
Resection status
R0	36 (40)
R1-2	5 (5.5)

¹The serum CEA level after recurrence;

²For the patients who underwent surgery;

³Including excision of uterus, vagina, seminal vesicle, prostate, and sacrum. CEA: Carcinoembryonic antigen.